Research & Policy

Cato Laurencin, M.D., Ph.D., a world-renowned physician and healthcare leader weighs in on how racism is a public health crisis and discusses the impact of recent protests in the midst of a pandemic

The COVID-19 pandemic has disrupted how we work, live, and behave. As the pandemic was expanding, so was the importance of science. Suddenly, I saw researchers and medical experts in the spotlight and playing crucial roles in political...

The competitive grants program is designed to support the next generation of researchers working on the front lines to advance understanding and awareness of central nervous system (CNS) disorders.

In Episode 7, Lisa Ling speaks with Johnson & Johnson Chief Scientific Officer Paul Stoffels, M.D., about important advances being made in vaccine development.

This new virtual lab will offer 400 high school students from backgrounds historically underrepresented in STEM a first-hand experience in biotechnology and provide the opportunity to learn directly from leading scientists at Biogen and MIT.

When faced with something overwhelming, terrifying, or incomprehensible, the human mind can get pretty creative.

In Episode 6, Ling talks with Jane Halton, Chair of the Coalition for Epidemic Preparedness Innovations, about her work to ensure people globally get access to vaccines.

The COVID‐19 crisis is accelerating the transformation of business – one that solidifies the private sector mandate of a stakeholder‐first, rather than shareholder‐only, mentality.

It was a year ago this month that Johnson & Johnson Innovation first unveiled plans to launch a healthcare innovation facility in Washington, D.C., in collaboration with BARDA—also known as the Biomedical Advanced Research and Development Authority

One easy way to help join the fight against COVID-19 is through IBM’s World Community Grid, which crowdsources the surplus computing power that volunteers like you and me have, and uses it for scientific research.